세계의 조영제 주입기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 종류별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Contrast Media Injectors Market Growth & Trends:

The global contrast media injectors market is expected to reach USD 3.75 billion by 2030, registering a CAGR of 10.87% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is expected to grow because of the rising demand for minimally invasive surgical procedures, along with the increasing usage of consumables for several diagnostic procedures, which are supporting the market growth of contrast media injectors.

COVID-19 had a significant impact on the contrast media injector market, in 2019, with around a 30-40% reduction in sales due to the imposed lockdown and rapid decline in imaging case volume. However, the market is expected to return to peak levels of 2019 by 2022. This is due to the launch of COVID-19 vaccines and ease in restrictions, import & export of raw materials have resumed; therefore, the market is expected to grow at a significant rate over the forecast period.

Technological advancements such as IT-enabled solutions for contrast media injectors, along with growing demand for minimally invasive surgical procedures, are expected to boost the market during the coming years. Furthermore, the large number of intraoperative imaging procedures being performed has further enhanced the demand for these injectors, propelling the market growth.

Contrast Media Injectors Market Report Highlights:

• By product, injector systems segment is the fastest growing, with a CAGR of 10.94% in the contrast media injector market, due to its growing application in the diagnosis and treatment of vascular disease, cancer, and others
• By type, the single-head injector segment dominated the contrast media injector market in 2024, because of their wide usage in the field of angiography, CT, and MRI as well these products are inexpensive
• Based on the application, the radiology segment dominated the market with around 45.47% of the revenue share in 2024, because it is the primary procedure used for the diagnosis of several chronic diseases
• Based on the end-use, the hospitals segment dominated the market with around 69.26% of the revenue share in 2024, due to the fact that these facilities are primary users of the contrast media injectors because of their need to record the rhythm & electrical activity and evaluate the results in detail for clinical & research purposes
• Asia Pacific region is one of the fastest-growing markets during the forecast period. Factors that can be attributed to market growth include the growing geriatric population and an increasing number of surgeries

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Type
  • 1.1.3. Application
  • 1.1.4. End-use
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Contrast Media Injectors Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing burden of chronic diseases
    • 3.2.1.2. Advancements in technology
    • 3.2.1.3. Growing demand for imaging tests
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Potential complications and risks associated with contrast media injections
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Expanding healthcare infrastructure in emerging markets
    • 3.2.3.2. Increasing research activities
    • 3.2.3.3. Growing adoption of syringeless products
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Shortage of radiologists and healthcare professionals
• 3.3. Contrast Media Injectors Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Contrast Media Injectors Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Contrast Media Injectors Market Product Movement Analysis
• 4.3. Global Contrast Media Injectors Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Injector Systems
  • 4.4.1. Injector systems market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4.2. CT injector systems
    • 4.4.2.1. CT injector systems market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4.3. MRI injector systems
    • 4.4.3.1. MRI injector systems market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4.4. Cardiovascular/angiography injector systems
    • 4.4.4.1. Cardiovascular/angiography injector systems market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Consumables
  • 4.5.1. Consumables market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Tubing
    • 4.5.2.1. Tubing market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.3. Syringe
    • 4.5.3.1. Syringe market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.4. Others
    • 4.5.4.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Contrast Media Injectors Market: Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Contrast Media Injectors Market Type Movement Analysis
• 5.3. Global Contrast Media Injectors Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 5.4. Single Head Injectors
  • 5.4.1. Single Head Injectors market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Dual-Head Injectors
  • 5.5.1. Dual-Head Injectors market estimates and forecast 2018 to 2030 (USD Million)
• 5.6. Syringeless Injectors
  • 5.6.1. Syringeless Injectors market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Contrast Media Injectors Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Contrast Media Injectors Market Type Movement Analysis
• 6.3. Global Contrast Media Injectors Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 6.4. Radiology
  • 6.4.1. Radiology Injectors market estimates and forecast 2018 to 2030 (USD Million)
• 6.5. Interventional Cardiology
  • 6.5.1. Interventional Cardiology market estimates and forecast 2018 to 2030 (USD Million)
• 6.6. Interventional Radiology
  • 6.6.1. Interventional Radiology market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Contrast Media Injectors: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Contrast Media Injectors Market End-Use Movement Analysis
• 7.3. Global Contrast Media Injectors Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
• 7.5. Diagnostic Centers
  • 7.5.1. Operating rooms market estimates and forecast 2018 to 2030 (USD Million)
• 7.6. Ambulatory Surgery Centers
  • 7.6.1. Ambulatory Surgery Centers market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Contrast Media Injectors Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 8.3. North America
  • 8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Competitive scenario
    • 8.3.2.3. Regulatory framework
    • 8.3.2.4. Reimbursement scenario
    • 8.3.2.5. U.S. market estimates and forecasts, 2018 - 2030
  • 8.3.3. Canada
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Competitive scenario
    • 8.3.3.3. Regulatory framework
    • 8.3.3.4. Reimbursement scenario
    • 8.3.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 8.3.4. Mexico
    • 8.3.4.1. Key country dynamics
    • 8.3.4.2. Competitive scenario
    • 8.3.4.3. Regulatory framework
    • 8.3.4.4. Reimbursement scenario
    • 8.3.4.5. Mexico market estimates and forecasts, 2018 - 2030
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Competitive scenario
    • 8.4.1.3. Regulatory framework
    • 8.4.1.4. Reimbursement scenario
    • 8.4.1.5. UK market estimates and forecasts, 2018 - 2030
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. Reimbursement scenario
    • 8.4.2.5. Germany market estimates and forecasts, 2018 - 2030
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. Reimbursement scenario
    • 8.4.3.5. France market estimates and forecasts, 2018 - 2030
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. Reimbursement scenario
    • 8.4.4.5. Italy market estimates and forecasts, 2018 - 2030
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Competitive scenario
    • 8.4.5.3. Regulatory framework
    • 8.4.5.4. Reimbursement scenario
    • 8.4.5.5. Spain market estimates and forecasts, 2018 - 2030
  • 8.4.6. Denmark
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Competitive scenario
    • 8.4.6.3. Regulatory framework
    • 8.4.6.4. Reimbursement scenario
    • 8.4.6.5. Denmark market estimates and forecasts, 2018 - 2030
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Competitive scenario
    • 8.4.7.3. Regulatory framework
    • 8.4.7.4. Reimbursement scenario
    • 8.4.7.5. Sweden market estimates and forecasts, 2018 - 2030
  • 8.4.8. Norway
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Competitive scenario
    • 8.4.8.3. Regulatory framework
    • 8.4.8.4. Reimbursement scenario
    • 8.4.8.5. Norway market estimates and forecasts, 2018 - 2030
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Competitive scenario
    • 8.5.1.3. Regulatory framework
    • 8.5.1.4. Reimbursement scenario
    • 8.5.1.5. Japan market estimates and forecasts, 2018 - 2030
  • 8.5.2. India
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. India market estimates and forecasts, 2018 - 2030
  • 8.5.3. China
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. China market estimates and forecasts, 2018 - 2030
  • 8.5.4. South Korea
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. South Korea market estimates and forecasts, 2018 - 2030
  • 8.5.5. Australia
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. Reimbursement scenario
    • 8.5.5.5. Australia market estimates and forecasts, 2018 - 2030
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Reimbursement scenario
    • 8.5.6.5. Thailand market estimates and forecasts, 2018 - 2030
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Competitive scenario
    • 8.6.1.3. Regulatory framework
    • 8.6.1.4. Reimbursement scenario
    • 8.6.1.5. Brazil market estimates and forecasts, 2018 - 2030
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. Argentina market estimates and forecasts, 2018 - 2030
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Competitive scenario
    • 8.7.1.3. Regulatory framework
    • 8.7.1.4. Reimbursement scenario
    • 8.7.1.5. South Africa market estimates and forecasts, 2018 - 2030
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. UAE market estimates and forecasts, 2018 - 2030
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement scenario
    • 8.7.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Key Company Profiles
  • 9.2.1. Bayer
    • 9.2.1.1. Company overview
    • 9.2.1.2. Financial performance
    • 9.2.1.3. Product benchmarking
    • 9.2.1.4. Strategic initiatives
  • 9.2.2. Bracco Group
    • 9.2.2.1. Company overview
    • 9.2.2.2. Financial performance
    • 9.2.2.3. Product benchmarking
    • 9.2.2.4. Strategic initiatives
  • 9.2.3. Ulrich Medical
    • 9.2.3.1. Company overview
    • 9.2.3.2. Financial performance
    • 9.2.3.3. Product benchmarking
    • 9.2.3.4. Strategic initiatives
  • 9.2.4. Guerbet Group
    • 9.2.4.1. Company overview
    • 9.2.4.2. Financial performance
    • 9.2.4.3. Product benchmarking
    • 9.2.4.4. Strategic initiatives
  • 9.2.5. Shenzhen Boon Medical Supply Co., Ltd
    • 9.2.5.1. Company overview
    • 9.2.5.2. Financial performance
    • 9.2.5.3. Product benchmarking
    • 9.2.5.4. Strategic initiatives
  • 9.2.6. B.Braun SE
    • 9.2.6.1. Company overview
    • 9.2.6.2. Financial performance
    • 9.2.6.3. Product benchmarking
    • 9.2.6.4. Strategic initiatives
  • 9.2.7. Shenzhen Antmed Co., Ltd.
    • 9.2.7.1. Company overview
    • 9.2.7.2. Financial performance
    • 9.2.7.3. Product benchmarking
    • 9.2.7.4. Strategic initiatives
  • 9.2.8. Siemens Medical Solutions USA, Inc. (Siemens Healthineers AG)
    • 9.2.8.1. Company overview
    • 9.2.8.2. Financial performance
    • 9.2.8.3. Product benchmarking
    • 9.2.8.4. Strategic initiatives
  • 9.2.9. Ecomed Solutions
    • 9.2.9.1. Company overview
    • 9.2.9.2. Financial performance
    • 9.2.9.3. Product benchmarking
    • 9.2.9.4. Strategic initiatives
  • 9.2.10. Nemoto Kyorindo Co., Ltd
    • 9.2.10.1. Company overview
    • 9.2.10.2. Financial performance
    • 9.2.10.3. Product benchmarking
    • 9.2.10.4. Strategic initiatives
  • 9.2.11. MEDTRON AG
    • 9.2.11.1. Company overview
    • 9.2.11.2. Financial performance
    • 9.2.11.3. Product benchmarking
    • 9.2.11.4. Strategic initiatives
• 9.3. Heat Map Analysis/ Company Market Position Analysis
• 9.4. Estimated Company Market Share Analysis, 2024
• 9.5. List of Other Key Market Players